Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis.

Dionisia QuirogaDavid A LiebnerJennifer S PhilipponSarah HoffmanYubo TanJames L ChenScott LenobelPaul E WakelyRaphael PollockGabriel Tinoco

Published in: BMC cancer (2020)

This study suggests activity of PD1i in a pretreated cohort of advanced sarcoma patients, particularly for the subset of patients with PD1 positive tumors. Our results highlight the importance of further research to better target the optimal patient population and markers of response.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
case report
patient reported outcomes